English
Insider transactions
EDGARInspireMD, Inc.
Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.
A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.
Window: transactions dated on or after 2025-11-16.
- Open-market purchases (code P)
- 17 transactions, 417,383 shares
- Sum of shares × price per share: 496,212.07
- Open-market sales (code S)
- 12 transactions, 86,913 shares
- Sum of shares × price per share: 127,012.533
Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.
Showing 1–50 of 53
| Date | Reporting owner | Code | Acquired or disposed | Shares | Price per share, as filed | Value (derived) | Shares owned after | Direct or indirect | Rule 10b5-1 box | Notes | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-18 Filed 2026-09-23 | ROUBIN GARY S Director | JOther acquisition or disposition (describe transaction) | Disposed (D) | 15,313 | 0 | — | 15,312 | Direct (D) | No | F1, F2
| Open filing 0001493152-26-043911 Read from the filing’s XML Dispute this row |
| 2026-09-18 Filed 2026-09-23 | ROUBIN GARY S Director | JOther acquisition or disposition (describe transaction) | Acquired (A) | 15,313 | 0 | — | 15,313 | Direct (D) | No | F1, F3
| Open filing 0001493152-26-043911 Read from the filing’s XML Dispute this row |
| 2026-09-18 Filed 2026-09-23 | ROUBIN GARY S Director | JOther acquisition or disposition (describe transaction) | Disposed (D) | 30,624 | 0 | — | 0 | Direct (D) | No | F4, F5
| Open filing 0001493152-26-043911 Read from the filing’s XML Dispute this row |
| 2026-09-18 Filed 2026-09-23 | ROUBIN GARY S Director | JOther acquisition or disposition (describe transaction) | Acquired (A) | 30,624 | 0 | — | 30,624 | Direct (D) | No | F4, F6
| Open filing 0001493152-26-043911 Read from the filing’s XML Dispute this row |
| 2026-09-18 Filed 2026-09-23 | Stuka Paul Director | JOther acquisition or disposition (describe transaction) | Disposed (D) | 43,750 | 0 | — | 43,750 | Indirect (I) See Footnote | No | F1, F2, F3
| Open filing 0001493152-26-043910 Read from the filing’s XML Dispute this row |
| 2026-09-18 Filed 2026-09-23 | Stuka Paul Director | JOther acquisition or disposition (describe transaction) | Acquired (A) | 43,750 | 0 | — | 43,750 | Indirect (I) See Footnote | No | F1, F4, F3
| Open filing 0001493152-26-043910 Read from the filing’s XML Dispute this row |
| 2026-09-18 Filed 2026-09-23 | Stuka Paul Director | JOther acquisition or disposition (describe transaction) | Disposed (D) | 87,500 | 0 | — | 0 | Indirect (I) See Footnote | No | F5, F6, F3
| Open filing 0001493152-26-043910 Read from the filing’s XML Dispute this row |
| 2026-09-18 Filed 2026-09-23 | Stuka Paul Director | JOther acquisition or disposition (describe transaction) | Acquired (A) | 87,500 | 0 | — | 43,750 | Indirect (I) See Footnote | No | F5, F7, F3
| Open filing 0001493152-26-043910 Read from the filing’s XML Dispute this row |
| 2026-09-18 Filed 2026-09-23 | BERMAN MICHAEL Director | JOther acquisition or disposition (describe transaction) | Disposed (D) | 30,625 | 0 | — | 30,624 | Indirect (I) See Footnote | No | F1, F2, F3
| Open filing 0001493152-26-043916 Read from the filing’s XML Dispute this row |
| 2026-09-18 Filed 2026-09-23 | BERMAN MICHAEL Director | JOther acquisition or disposition (describe transaction) | Acquired (A) | 30,625 | 0 | — | 30,625 | Indirect (I) See Footnote | No | F1, F4, F3
| Open filing 0001493152-26-043916 Read from the filing’s XML Dispute this row |
| 2026-09-18 Filed 2026-09-23 | BERMAN MICHAEL Director | JOther acquisition or disposition (describe transaction) | Disposed (D) | 61,248 | 0 | — | 0 | Indirect (I) See Footnote | No | F5, F6, F3
| Open filing 0001493152-26-043916 Read from the filing’s XML Dispute this row |
| 2026-09-18 Filed 2026-09-23 | BERMAN MICHAEL Director | JOther acquisition or disposition (describe transaction) | Acquired (A) | 61,248 | 0 | — | 61,248 | Indirect (I) See Footnote | No | F5, F7, F3
| Open filing 0001493152-26-043916 Read from the filing’s XML Dispute this row |
| 2026-05-27 Filed 2026-05-29 | Stuka Paul Director | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 20,000 | 0.8750 | 17,500Derived: shares × price per share. Exact value 17500.0000. | 667,871 | Direct (D) | No | F1
| Open filing 0001493152-26-026348 Read from the filing’s XML Dispute this row |
| 2026-05-19 Filed 2026-05-21 | Gleason Shane Thomas Officer: Chief Commercial Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 22,778 | 1.01 | 23,005.78Derived: shares × price per share. Exact value 23005.78. | 1,053,882 | Direct (D) | No | F1, F2
| Open filing 0001493152-26-024864 Read from the filing’s XML Dispute this row |
| 2026-05-14 Filed 2026-05-15 | Stuka Paul Director | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 5,000 | 1.15 | 5,750Derived: shares × price per share. Exact value 5750.00. | 647,871 | Direct (D) | No | — | Open filing 0001493152-26-023727 Read from the filing’s XML Dispute this row |
| 2026-05-13 Filed 2026-05-15 | Stuka Paul Director | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 10,000 | 1.1575 | 11,575Derived: shares × price per share. Exact value 11575.0000. | 642,871 | Direct (D) | No | F1
| Open filing 0001493152-26-023727 Read from the filing’s XML Dispute this row |
| 2026-05-12 Filed 2026-05-13 | Slosman Marvin Director · Officer: CEO and President | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 21,000 | 1.20 | 25,200Derived: shares × price per share. Exact value 25200.00. | 3,556,658 | Direct (D) | No | — | Open filing 0001493152-26-022775 Read from the filing’s XML Dispute this row |
| 2026-05-11 Filed 2026-05-13 | Stuka Paul Director | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 10,000 | 1.19 | 11,900Derived: shares × price per share. Exact value 11900.00. | 632,871 | Direct (D) | No | F6, F4
| Open filing 0001493152-26-022763 Read from the filing’s XML Dispute this row |
| 2026-05-11 Filed 2026-05-12 | Stuka Paul Director | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 10,000 | 1.19 | 11,900Derived: shares × price per share. Exact value 11900.00. | 632,871 | Direct (D) | Yes | F4
| Open filing 0001493152-26-022564 Read from the filing’s XML Dispute this row |
| 2026-05-08 Filed 2026-05-13 | Stuka Paul Director | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 65,626 | 1.16 | 76,126.16Derived: shares × price per share. Exact value 76126.16. | 622,871 | Direct (D) | No | F6, F1, F2, F3
| Open filing 0001493152-26-022763 Read from the filing’s XML Dispute this row |
| 2026-05-08 Filed 2026-05-12 | Stuka Paul Director | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 65,626 | 1.16 | 76,126.16Derived: shares × price per share. Exact value 76126.16. | 622,871 | Direct (D) | Yes | F1, F2, F3
| Open filing 0001493152-26-022564 Read from the filing’s XML Dispute this row |
| 2026-05-07 Filed 2026-05-08 | ROUBIN GARY S Director | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 90,000 | 1.18 | 106,200Derived: shares × price per share. Exact value 106200.00. | 834,478 | Direct (D) | No | F1
| Open filing 0001493152-26-022013 Read from the filing’s XML Dispute this row |
| 2026-05-07 Filed 2026-05-08 | Ward Scott R. Director | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 73,255 | 1.15 | 84,243.25Derived: shares × price per share. Exact value 84243.25. | 237,096 | Direct (D) | No | — | Open filing 0001493152-26-022020 Read from the filing’s XML Dispute this row |
| 2026-05-07 Filed 2026-05-08 | Stuka Paul Director | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 6,378 | 1.15 | 7,334.7Derived: shares × price per share. Exact value 7334.70. | 531,599 | Direct (D) | No | F1
| Open filing 0001493152-26-022016 Read from the filing’s XML Dispute this row |
| 2026-05-06 Filed 2026-05-08 | Ward Scott R. Director | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 15,995 | 1.15 | 18,394.25Derived: shares × price per share. Exact value 18394.25. | 163,841 | Direct (D) | No | F1
| Open filing 0001493152-26-022020 Read from the filing’s XML Dispute this row |
| 2026-05-06 Filed 2026-05-08 | Stuka Paul Director | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 1,517 | 1.12 | 1,699.04Derived: shares × price per share. Exact value 1699.04. | 525,221 | Direct (D) | No | — | Open filing 0001493152-26-022016 Read from the filing’s XML Dispute this row |
| 2026-02-02 Filed 2026-05-21 | Gleason Shane Thomas Officer: Chief Commercial Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 2,941 | 1.59 | 4,676.19Derived: shares × price per share. Exact value 4676.19. | 1,076,660 | Direct (D) | No | F1
| Open filing 0001493152-26-024864 Read from the filing’s XML Dispute this row |
| 2026-02-02 Filed 2026-02-02 | Gleason Shane Thomas Officer: Chief Commercial Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 2,000 | 1.604 | 3,208Derived: shares × price per share. Exact value 3208.000. | 1,139,177 | Direct (D) | No | F1
| Open filing 0001493152-26-004773 Read from the filing’s XML Dispute this row |
| 2026-01-30 Filed 2026-02-02 | Gleason Shane Thomas Officer: Chief Commercial Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 2,900 | 1.631 | 4,729.9Derived: shares × price per share. Exact value 4729.900. | 1,141,177 | Direct (D) | No | F1
| Open filing 0001493152-26-004773 Read from the filing’s XML Dispute this row |
| 2026-01-29 Filed 2026-02-02 | Gleason Shane Thomas Officer: Chief Commercial Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 5,000 | 1.650 | 8,250Derived: shares × price per share. Exact value 8250.000. | 1,144,077 | Direct (D) | No | F1
| Open filing 0001493152-26-004773 Read from the filing’s XML Dispute this row |
| 2026-01-28 Filed 2026-02-02 | Gleason Shane Thomas Officer: Chief Commercial Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 12,395 | 1.651 | 20,464.145Derived: shares × price per share. Exact value 20464.145. | 1,149,077 | Direct (D) | No | F1
| Open filing 0001493152-26-004773 Read from the filing’s XML Dispute this row |
| 2026-01-27 Filed 2026-02-02 | Gleason Shane Thomas Officer: Chief Commercial Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 4,781 | 1.664 | 7,955.584Derived: shares × price per share. Exact value 7955.584. | 1,161,472 | Direct (D) | No | F1
| Open filing 0001493152-26-004773 Read from the filing’s XML Dispute this row |
| 2026-01-22 Filed 2026-02-02 | Gleason Shane Thomas Officer: Chief Commercial Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 8,411 | 1.574 | 13,238.914Derived: shares × price per share. Exact value 13238.914. | 1,166,253 | Direct (D) | No | F1
| Open filing 0001493152-26-004773 Read from the filing’s XML Dispute this row |
| 2026-01-21 Filed 2026-02-02 | Gleason Shane Thomas Officer: Chief Commercial Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 17,593 | 1.623 | 28,553.439Derived: shares × price per share. Exact value 28553.439. | 1,174,664 | Direct (D) | No | F1
| Open filing 0001493152-26-004773 Read from the filing’s XML Dispute this row |
| 2026-01-20 Filed 2026-02-02 | Gleason Shane Thomas Officer: Chief Commercial Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 2,955 | 1.594 | 4,710.27Derived: shares × price per share. Exact value 4710.270. | 1,192,257 | Direct (D) | No | F1
| Open filing 0001493152-26-004773 Read from the filing’s XML Dispute this row |
| 2026-01-16 Filed 2026-02-02 | Gleason Shane Thomas Officer: Chief Commercial Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 2,250 | 1.612 | 3,627Derived: shares × price per share. Exact value 3627.000. | 1,195,212 | Direct (D) | No | F1
| Open filing 0001493152-26-004773 Read from the filing’s XML Dispute this row |
| 2026-01-15 Filed 2026-02-02 | Gleason Shane Thomas Officer: Chief Commercial Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 2,909 | 1.579 | 4,593.311Derived: shares × price per share. Exact value 4593.311. | 1,197,462 | Direct (D) | No | F1
| Open filing 0001493152-26-004773 Read from the filing’s XML Dispute this row |
| 2026-01-14 Filed 2026-01-16 | BERMAN MICHAEL Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 88,053 | 0 | — | 352,586 | Direct (D) | No | F1
| Open filing 0001493152-26-002662 Read from the filing’s XML Dispute this row |
| 2026-01-14 Filed 2026-01-16 | Stuka Paul Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 132,076 | 0 | — | 523,704 | Direct (D) | No | F1
| Open filing 0001493152-26-002669 Read from the filing’s XML Dispute this row |
| 2026-01-14 Filed 2026-01-16 | Tommasoli Andrea Officer: Chief Operating Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 226,695 | 0 | — | 954,389 | Direct (D) | No | F1
| Open filing 0001493152-26-002670 Read from the filing’s XML Dispute this row |
| 2026-01-14 Filed 2026-01-16 | Dearen Danny L. Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 44,030 | 0 | — | 102,047 | Direct (D) | No | F1
| Open filing 0001493152-26-002664 Read from the filing’s XML Dispute this row |
| 2026-01-14 Filed 2026-01-16 | COHEN RAYMOND W Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 44,030 | 0 | — | 92,417 | Direct (D) | No | F1
| Open filing 0001493152-26-002663 Read from the filing’s XML Dispute this row |
| 2026-01-14 Filed 2026-01-16 | Gleason Shane Thomas Officer: Chief Commercial Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 453,390 | 0 | — | 1,200,371 | Direct (D) | No | F1
| Open filing 0001493152-26-002665 Read from the filing’s XML Dispute this row |
| 2026-01-14 Filed 2026-01-16 | Slosman Marvin Director · Officer: CEO and President | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 1,114,792 | 0 | — | 3,535,658 | Direct (D) | No | F1
| Open filing 0001493152-26-002668 Read from the filing’s XML Dispute this row |
| 2026-01-14 Filed 2026-01-16 | Ward Scott R. Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 88,053 | 0 | — | 147,846 | Direct (D) | No | F1
| Open filing 0001493152-26-002671 Read from the filing’s XML Dispute this row |
| 2026-01-14 Filed 2026-01-16 | ROUBIN GARY S Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 88,053 | 0 | — | 744,478 | Direct (D) | No | F1
| Open filing 0001493152-26-002667 Read from the filing’s XML Dispute this row |
| 2026-01-14 Filed 2026-01-16 | Lawless Michael A Officer: Chief Financial Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 226,695 | 0 | — | 691,695 | Direct (D) | No | F1
| Open filing 0001493152-26-002666 Read from the filing’s XML Dispute this row |
| 2025-12-30 Filed 2025-12-31 | Arnold Kathryn Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 55,556 | 0 | — | 303,087 | Direct (D) | No | F1
| Open filing 0001493152-25-029800 Read from the filing’s XML Dispute this row |
| 2025-12-30 Filed 2025-12-31 | Arnold Kathryn Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 26,276 | 0 | — | 111,221 | Direct (D) | No | F1
| Open filing 0001493152-25-029800 Read from the filing’s XML Dispute this row |
| 2025-12-09 Filed 2026-02-23 | Stuka Paul Director | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 2,710 | 1.81 | 4,905.1Derived: shares × price per share. Exact value 4905.10. | 391,628 | Direct (D) | No | F1, F2
| Open filing 0001493152-26-007752 Read from the filing’s XML Dispute this row |
Institutional holders (Form 13F)
Quarter ending 2026-09-30: 7,211 filings read, the latest filed 2026-11-13. Prior quarter ending 2026-06-30: 9,150 filings read.
Showing 1–28 of 28
| Manager | Shares or principal | Value as filed | Change from the prior quarter | Source |
|---|---|---|---|---|
| Aberdeen Group plc Partly reported under another manager | 3,698,364 SH | 2,482,712 dollars | Unchanged Prior quarter: 3,698,364 | Open filing 0001716774-26-000032 Filed 2026-11-10 Dispute this row |
| Nantahala Capital Management, LLC | 3,376,484 SH | 2,254,816 dollars | Lower by 3,376,484 Prior quarter: 6,752,968 | Open filing 0001104659-26-127125 Filed 2026-11-13 Dispute this row |
| MARSHALL WACE, LLP Partly reported under another manager | 1,860,405 SH | 1,246,471 dollars | Unchanged Prior quarter: 1,860,405 | Open filing 0001318757-26-000012 Filed 2026-11-13 Dispute this row |
| INGALLS SNYDER LLC | 362,550 SH | 242 dollars | Lower by 6,250 Prior quarter: 368,800 | Open filing 0001041885-26-000010 Filed 2026-11-12 Dispute this row |
| Affiance Financial, LLC | 250,370 SH | 167,197 dollars | Unchanged Prior quarter: 250,370 | Open filing 0001723681-26-000006 Filed 2026-10-15 Dispute this row |
| UBS Group AG Partly reported under another manager | 133,653 SH | 89,280 dollars | Higher by 128,339 Prior quarter: 5,314 | Open filing 0001610520-26-000121 Filed 2026-11-10 Dispute this row |
| BlackRock, Inc. Partly reported under another manager | 117,708 SH | 78,605 dollars | Lower by 5,285 Prior quarter: 122,993 | Open filing 0002012383-26-003985 Filed 2026-11-13 Dispute this row |
| Creative Planning | 108,964 SH | 72,766 dollars | Unchanged Prior quarter: 108,964 | Open filing 0001540235-26-000006 Filed 2026-11-02 Dispute this row |
| RENAISSANCE TECHNOLOGIES LLC Partly reported under another manager | 87,892 SH | 58,694 dollars | Lower by 24,940 Prior quarter: 112,832 | Open filing 0001037389-26-000062 Filed 2026-11-12 Dispute this row |
| COURIER CAPITAL LLC | 30,000 SH | 20,034 dollars | Unchanged Prior quarter: 30,000 | Open filing 0001420506-26-002338 Filed 2026-10-19 Dispute this row |
| Mesirow Financial Investment Management, Inc. | 30,000 SH | 20,034 dollars | Unchanged Prior quarter: 30,000 | Open filing 0001469475-26-000005 Filed 2026-11-05 Dispute this row |
| Centiva Capital, LP | 27,180 SH | 18,246 dollars | Lower by 16,943 Prior quarter: 44,123 | Open filing 0001172661-26-005016 Filed 2026-11-13 Dispute this row |
| VESTIA PERSONAL WEALTH ADVISORS | 24,425 SH | 16,311 dollars | Unchanged Prior quarter: 24,425 | Open filing 0002033299-26-000005 Filed 2026-10-20 Dispute this row |
| JANE STREET GROUP, LLC Partly reported under another manager | 20,402 SH | 13,625 dollars | Not in the prior quarter’s filings read | Open filing 0001595888-26-000162 Filed 2026-11-12 Dispute this row |
| MORGAN STANLEY Partly reported under another manager | 20,371 SH | 13,604 dollars | Lower by 8,000 Prior quarter: 28,371 | Open filing 0000895421-26-000309 Filed 2026-11-13 Dispute this row |
| Cambridge Investment Research Advisors, Inc. | 20,116 SH | 13 dollars | Lower by 20,216 Prior quarter: 40,332 | Open filing 0001419186-26-000008 Filed 2026-11-02 Dispute this row |
| HRT FINANCIAL LP | 19,346 SH | 12 dollars | Lower by 40,408 Prior quarter: 59,754 | Open filing 0001475597-26-000249 Filed 2026-11-13 Dispute this row |
| LPL Financial LLC | 18,621 SH | 12,435 dollars | Unchanged Prior quarter: 18,621 | Open filing 0001403438-26-000005 Filed 2026-11-06 Dispute this row |
| OSAIC HOLDINGS, INC. Partly reported under another manager | 15,952 SH | 10,685 dollars | Unchanged Prior quarter: 15,952 | Open filing 0001677044-26-000011 Filed 2026-11-12 Dispute this row |
| Avestar Capital, LLC | 15,000 SH | 10,017 dollars | Unchanged Prior quarter: 15,000 | Open filing 0001172661-26-004738 Filed 2026-10-28 Dispute this row |
| Pallas Capital Advisors LLC | 11,000 SH | 7,346 dollars | Unchanged Prior quarter: 11,000 | Open filing 0001951757-26-001856 Filed 2026-11-12 Dispute this row |
| McKinley Carter Wealth Services, Inc. | 10,000 SH | 6,678 dollars | Unchanged Prior quarter: 10,000 | Open filing 0001484265-26-000004 Filed 2026-10-16 Dispute this row |
| BFC Planning, Inc. | 8,000 SH | 5,342 dollars | Unchanged Prior quarter: 8,000 | Open filing 0001420506-26-002645 Filed 2026-11-13 Dispute this row |
| Farther Finance Advisors, LLC | 1,000 SH | 668 dollars | Unchanged Prior quarter: 1,000 | Open filing 0001992825-26-000006 Filed 2026-10-08 Dispute this row |
| CITIGROUP INC Partly reported under another manager | 400 SH | 269 dollars | Higher by 399 Prior quarter: 1 | Open filing 0000831001-26-000052 Filed 2026-11-04 Dispute this row |
| SIMPLEX TRADING, LLC Option: Call | 200 SH | 15 dollars | Not in the prior quarter’s filings read | Open filing 0001488542-26-000013 Filed 2026-11-04 Dispute this row |
| HARBOUR INVESTMENTS, INC. | 14 SH | 9 dollars | Not in the prior quarter’s filings read | Open filing 0000810121-26-000006 Filed 2026-11-09 Dispute this row |
| Caitong International Asset Management Co., Ltd | 1 SH | 1 dollars | Unchanged Prior quarter: 1 | Open filing 0001628280-26-068135 Filed 2026-10-29 Dispute this row |
Managers in the prior quarter with no filing read for the latest
They may simply not have filed yet: absent from the latest quarter’s filings read is not the same as a position sold.
- Rosalind Advisors, Inc. 3,905,743 SH
- ORBIMED ADVISORS LLC 3,133,405 SH
- Parkman Healthcare Partners LLC 2,416,518 SH
- Soleus Capital Management, L.P. 1,045,708 SH
- PURA VIDA INVESTMENTS, LLC 450,517 SH
- Velan Capital Investment Management LP 148,138 SH
- Schonfeld Strategic Advisors LLC 99,275 SH
- XTX Topco Ltd 49,029 SH
- MILLENNIUM MANAGEMENT LLC 37,677 SH
- SUSQUEHANNA INTERNATIONAL GROUP, LLP 20,594 SH
- CITADEL ADVISORS LLC 13,600 SH
- AdvisorNet Financial, Inc 8,783 SH
- SIMPLEX TRADING, LLC 745 SH
- ROYAL BANK OF CANADA 247 SH
- Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
- A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
- A change is the difference between two quarter-end snapshots, not a trade.
- A position reported under another manager may also appear in that manager’s filing; rows are not added together.
- Holdings the securities list cannot place with this company, or places ambiguously, are not shown.
5% holders (Schedule 13D and 13G)
Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.
| Holder | Percent of class | Shares held | Event date | Form | Source |
|---|---|---|---|---|---|
| Nantahala Capital Management, LLC Common Stock, par value $0.0001 per share | 9.99 | 4,819,647.00 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G/AAmendment 5 | Open filing 0001104659-26-062712 Dispute this row |
| Wilmot B. Harkey Common Stock, par value $0.0001 per share | 9.99 | 4,819,647.00 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G/AAmendment 5 | Open filing 0001104659-26-062712 Dispute this row |
| Daniel Mack Common Stock, par value $0.0001 per share | 9.99 | 4,819,647.00 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G/AAmendment 5 | Open filing 0001104659-26-062712 Dispute this row |
| Velan Capital Master Fund LP Common Stock, par value $0.0001 per share | 4.99 | 2,347,779.00 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G/AAmendment 1 | Open filing 0000921895-26-001363 Dispute this row |
| Velan Capital Holdings LLC Common Stock, par value $0.0001 per share | 4.99 | 2,347,779.00 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G/AAmendment 1 | Open filing 0000921895-26-001363 Dispute this row |
| Velan Capital Investment Management LP Common Stock, par value $0.0001 per share | 4.99 | 2,347,779.00 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G/AAmendment 1 | Open filing 0000921895-26-001363 Dispute this row |
| Velan Capital Management LLC Common Stock, par value $0.0001 per share | 4.99 | 2,347,779.00 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G/AAmendment 1 | Open filing 0000921895-26-001363 Dispute this row |
| Morgan Adam Common Stock, par value $0.0001 per share | 4.99 | 2,347,779.00 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G/AAmendment 1 | Open filing 0000921895-26-001363 Dispute this row |
| Venkataraman Balaji Common Stock, par value $0.0001 per share | 4.99 | 2,347,779.00 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G/AAmendment 1 | Open filing 0000921895-26-001363 Dispute this row |
| Marvin Slosman Common Stock, $0.0001 par value per share | 5.18 | 2,556,760.00 | 01/22/2026 Filed 2026-04-24 | SCHEDULE 13D | Open filing 0001493152-26-018952 Dispute this row |
| ORBIMED ADVISORS LLC Common Stock, par value $0.0001 per share | 7.4 | 3,133,405.00 | 12/31/2025 Filed 2026-02-17 | SCHEDULE 13G | Open filing 0000947871-26-000191 Dispute this row |
| OrbiMed Capital GP IX LLC Common Stock, par value $0.0001 per share | 6.8 | 2,878,704.00 | 12/31/2025 Filed 2026-02-17 | SCHEDULE 13G | Open filing 0000947871-26-000191 Dispute this row |
| Rosalind Advisors, Inc. Common Shares | 9.2 | 10,987,104.00 | 12/31/2025 Filed 2026-02-11 | SCHEDULE 13G/AAmendment 9 | Open filing 0001622627-26-000006 Dispute this row |
| SALAMON STEVEN A J Common Shares | 9.2 | 10,987,104.00 | 12/31/2025 Filed 2026-02-11 | SCHEDULE 13G/AAmendment 9 | Open filing 0001622627-26-000006 Dispute this row |
| Aharon Gil Common Shares | 9.2 | 10,987,104.00 | 12/31/2025 Filed 2026-02-11 | SCHEDULE 13G/AAmendment 9 | Open filing 0001622627-26-000006 Dispute this row |
| Rosalind Master Fund L.P. Common Shares | 8.3 | 9,485,697.00 | 12/31/2025 Filed 2026-02-11 | SCHEDULE 13G/AAmendment 9 | Open filing 0001622627-26-000006 Dispute this row |
| Rosalind Opportunities Fund I L.P. Common Shares | 1.0 | 1,501,407.00 | 12/31/2025 Filed 2026-02-11 | SCHEDULE 13G/AAmendment 9 | Open filing 0001622627-26-000006 Dispute this row |
| Aberdeen Group plc Common Stock, $0.0001 par value per share | 7.49 | 3,173,364 | 12/31/2025 Filed 2026-02-02 | SCHEDULE 13G/AAmendment 1 | Open filing 0001716774-26-000010 Dispute this row |
| abrdn Inc. Common Stock, $0.0001 par value per share | 7.49 | 3,173,364 | 12/31/2025 Filed 2026-02-02 | SCHEDULE 13G/AAmendment 1 | Open filing 0001716774-26-000010 Dispute this row |
| Aberdeen Group plc Common Stock, $0.0001 par value per share | 5.95 | 2,481,117 | 10/01/2025 Filed 2025-11-07 | SCHEDULE 13G | Open filing 0001716774-25-000006 Dispute this row |
| abrdn Inc. Common Stock, $0.0001 par value per share | 5.95 | 2,481,117 | 10/01/2025 Filed 2025-11-07 | SCHEDULE 13G | Open filing 0001716774-25-000006 Dispute this row |
| Nantahala Capital Management, LLC Common Stock, par value $0.0001 per share | 9.99 | 4,255,729.00 | 09/30/2025 Filed 2025-11-14 | SCHEDULE 13G/AAmendment 1 | Open filing 0001104659-25-112683 Dispute this row |
| Wilmot B. Harkey Common Stock, par value $0.0001 per share | 9.99 | 4,255,729.00 | 09/30/2025 Filed 2025-11-14 | SCHEDULE 13G/AAmendment 1 | Open filing 0001104659-25-112683 Dispute this row |
| Daniel Mack Common Stock, par value $0.0001 per share | 9.99 | 4,255,729.00 | 09/30/2025 Filed 2025-11-14 | SCHEDULE 13G/AAmendment 1 | Open filing 0001104659-25-112683 Dispute this row |
| Parkman Healthcare Partners LLC Common Stock, $0.0001 par value | 5.8 | 2,440,633.00 | 09/30/2025 Filed 2025-11-14 | SCHEDULE 13G | Open filing 0000919574-25-006898 Dispute this row |
| Parkman Healthcare Partners Holdings LP Common Stock, $0.0001 par value | 5.8 | 2,440,633.00 | 09/30/2025 Filed 2025-11-14 | SCHEDULE 13G | Open filing 0000919574-25-006898 Dispute this row |
| Parkman Healthcare Partners Holdings GP LLC Common Stock, $0.0001 par value | 5.8 | 2,440,633.00 | 09/30/2025 Filed 2025-11-14 | SCHEDULE 13G | Open filing 0000919574-25-006898 Dispute this row |
| Martinez Gregory Common Stock, $0.0001 par value | 5.8 | 2,440,633.00 | 09/30/2025 Filed 2025-11-14 | SCHEDULE 13G | Open filing 0000919574-25-006898 Dispute this row |
| OrbiMed Advisors LLC Common Stock, par value $0.0001 per share | 4.1 | 2,133,405.00 | 09/30/2025 Filed 2025-11-14 | SCHEDULE 13G/AAmendment 3 | Open filing 0000947871-25-001021 Dispute this row |
| MARSHALL WACE, LLP Common Stock, par value $0.0001 per share | 9.99 | 28,103,699.00 | 09/30/2025 Filed 2025-11-14 | SCHEDULE 13G/AAmendment 1 | Open filing 0000902664-25-005052 Dispute this row |
| NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP Common Stock, par value $0.0001 per share | 5.6761 | 2,418,016.00 | 09/30/2025 Filed 2025-11-14 | SCHEDULE 13G/AAmendment 1 | Open filing 0001104659-25-112616 Dispute this row |
| Rosalind Advisors, Inc. Common Shares | 9.4 | 10,987,104.00 | 08/01/2025 Filed 2025-08-11 | SCHEDULE 13G/AAmendment 8 | Open filing 0001579206-25-000006 Dispute this row |
| SALAMON STEVEN A J Common Shares | 9.4 | 10,987,104.00 | 08/01/2025 Filed 2025-08-11 | SCHEDULE 13G/AAmendment 8 | Open filing 0001579206-25-000006 Dispute this row |
| Aharon Gil Common Shares | 9.4 | 10,987,104.00 | 08/01/2025 Filed 2025-08-11 | SCHEDULE 13G/AAmendment 8 | Open filing 0001579206-25-000006 Dispute this row |
| Rosalind Master Fund L.P. Common Shares | 8.4 | 9,485,697.00 | 08/01/2025 Filed 2025-08-11 | SCHEDULE 13G/AAmendment 8 | Open filing 0001579206-25-000006 Dispute this row |
| Rosalind Opportunities Fund I L.P. Common Shares | 0.1 | 1,501,407.00 | 08/01/2025 Filed 2025-08-11 | SCHEDULE 13G/AAmendment 8 | Open filing 0001579206-25-000006 Dispute this row |
| Rosalind Advisors, Inc. Common Shares | 9.9 | 10,987,104.00 | 08/01/2025 Filed 2025-08-11 | SCHEDULE 13G/AAmendment 8 | Open filing 0001579206-25-000008 Dispute this row |
| SALAMON STEVEN A J Common Shares | 9.9 | 10,987,104.00 | 08/01/2025 Filed 2025-08-11 | SCHEDULE 13G/AAmendment 8 | Open filing 0001579206-25-000008 Dispute this row |
| Aharon Gil Common Shares | 9.9 | 10,987,104.00 | 08/01/2025 Filed 2025-08-11 | SCHEDULE 13G/AAmendment 8 | Open filing 0001579206-25-000008 Dispute this row |
| Rosalind Master Fund L.P. Common Shares | 9.9 | 9,485,697.00 | 08/01/2025 Filed 2025-08-11 | SCHEDULE 13G/AAmendment 8 | Open filing 0001579206-25-000008 Dispute this row |
| Rosalind Opportunities Fund I L.P. Common Shares | 3.5 | 1,501,407.00 | 08/01/2025 Filed 2025-08-11 | SCHEDULE 13G/AAmendment 8 | Open filing 0001579206-25-000008 Dispute this row |
| Velan Capital Master Fund LP Common Stock, par value $0.0001 per share | 5.1 | 2,143,698.00 | 07/30/2025 Filed 2025-08-06 | SCHEDULE 13G | Open filing 0000921895-25-002116 Dispute this row |
| Velan Capital Holdings LLC Common Stock, par value $0.0001 per share | 5.1 | 2,143,698.00 | 07/30/2025 Filed 2025-08-06 | SCHEDULE 13G | Open filing 0000921895-25-002116 Dispute this row |
| Velan Capital Investment Management LP Common Stock, par value $0.0001 per share | 5.1 | 2,143,698.00 | 07/30/2025 Filed 2025-08-06 | SCHEDULE 13G | Open filing 0000921895-25-002116 Dispute this row |
| Velan Capital Management LLC Common Stock, par value $0.0001 per share | 5.1 | 2,143,698.00 | 07/30/2025 Filed 2025-08-06 | SCHEDULE 13G | Open filing 0000921895-25-002116 Dispute this row |
| Morgan Adam Common Stock, par value $0.0001 per share | 5.1 | 2,143,698.00 | 07/30/2025 Filed 2025-08-06 | SCHEDULE 13G | Open filing 0000921895-25-002116 Dispute this row |
| Venkataraman Balaji Common Stock, par value $0.0001 per share | 5.1 | 2,143,698.00 | 07/30/2025 Filed 2025-08-06 | SCHEDULE 13G | Open filing 0000921895-25-002116 Dispute this row |
| Craig Shore Common Stock, $0.0001 par value per share | 3.5 | 1,484,505.00 | 06/26/2025 Filed 2025-10-29 | SCHEDULE 13D/AAmendment 1 | Open filing 0001493152-25-020079 Dispute this row |
| Michael A. Lawless Common Stock, $0.0001 par value per share | 8.6 | 3,614,731.00 | 06/26/2025 Filed 2025-10-29 | SCHEDULE 13D | Open filing 0001493152-25-020078 Dispute this row |
| Rosalind Advisors, Inc. Common Shares | 9.4 | 10,987,104.00 | 03/31/2025 Filed 2025-08-11 | SCHEDULE 13G/AAmendment 8 | Open filing 0001579206-25-000005 Dispute this row |
Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.
What was read
2,092,408 filings read, dated 2004-06-14 to 2026-11-13: Forms 3, 3/A, 4, 4/A, 5, 5/A.
Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.
| Filing year | Filings read |
|---|---|
| 2015 | 1 |
| 2016 | 204,322 |
| 2017 | 202,494 |
| 2018 | 202,048 |
| 2019 | 193,638 |
| 2020 | 144,184 |
| 2021 | 224,474 |
| 2022 | 40,015 |
| 2023 | 199,811 |
| 2024 | 185,386 |
| 2025 | 235,520 |
| 2026 | 254,737 |
Filings made before the SEC required XML are listed, not extracted.